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Background: The development of the nervous system is a highly organized process involving the precise and
coordinated timing of many complex events. These events require proper expression of genes promoting
survival, differentiation, and maturation, but also repression of alternative cell fates and restriction of cell-
type-speciﬁc gene expression.
Scope of the review: As the enzymes mediating post-translational histone acetylation and methylation are
regulating higher order chromatin structure and controlling gene transcription, knowledge of the roles for
these enzymes becomes crucial for understanding neural development and disease. The widespread
expression and general biological roles for chromatin-modifying factors have hampered the studies of such
enzymes in neural development, but in recent years, in vivo and in vitro studies have started to shed light on
the various processes these enzymes regulate. In this review we summarize the implications of chromatin-
modifying enzymes in neural development, with particular emphasis on enzymes regulating histone
acetylation and methylation.
Major conclusions: Enzymes controlling histone acetylation and methylation are involved in the whole
process of neural development, from controlling proliferation and undifferentiated, “poised”, state of stem
cells to promoting and inhibiting neurogenic and gliogenic pathways and neuronal survival as well as neurite
outgrowth.
General signiﬁcance: Aberrant enzymatic activities of histone acetyl transferases, deacetylases, and demethylases
have been chemically and genetically associatedwith neural developmental disorders and cancer. Future studies
may aim at linking the genetic and developmental studies to more in-depth biochemical characterization to
provide a clearer picture of how to improve the diagnosis, prognosis, and treatment of such disorders. This article
is part of a Special Issue entitled Biochemistry of Stem Cells.© 2012 Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
The control of transcription is crucial in cell differentiation and
development of the nervous system. In the last decade, histone
modiﬁcations have been shown to control many aspects of transcrip-
tion including higher order chromatin structure and gene expression.
The enzymes mediating post-translational histone modiﬁcations are
therefore at the heart of development that requires precise control of
gene expression patterns. The concept of the self-renewing, multi-
potent neural stem cells generating the main cell types of the nervous
system has received a lot of attention and identiﬁcation of adult
neural stem cells residing in spinal cord and dentate gyrus has excitingly
triggered a vision of enabling neural-replacement strategies solving
severe disease situations, like spinal cord injuries or neurodegenerative
diseases, by promoting a functional recovery (cf [1]). Characterizingmistry of Stem Cells.
n).
-ND license.epigenetic cell state regulation is essential in many aspects for normal
development but also to understand developmental disorders. Impor-
tantly, epigenetic processes are also inﬂuenced by environmental cues
likematernal behavior or prenatal stress and have shown to be central in
inﬂuencing responses in the offspring [2,3]. From epigenetic studies it
has become clear that histone-modifying enzymes control transcription
both through their cell-type speciﬁc expression and their speciﬁc
activity. Histones can be post-translationally modiﬁed in many ways,
for example by acetylation, methylation, phosphorylation, ubiquitina-
tion, and sumoylation [4]. These modiﬁcations have profound effects on
the local chromatin environment and themodiﬁcations can be regulated
by active addition or removal. Hence, the enzymes regulating these
modiﬁcations become focus of attention when dissecting the epigenetic
mechanisms inﬂuencing neural stem cell state and fate and nervous
system development. In this reviewwe aim to present the implications of
the speciﬁc enzymes with activities modulating acetylation, i.e. histone
acetyl transferases and histone deacetylases, andmethylation, i.e. histone
methyl transferases and histone demethylases, of lysines of the histone
tails identiﬁed to be involved in neural development. These ﬁndings have
Table 1
Histone modifying enzymes involved in neural development. References for the table:
[7,10–15,21,22,24–27,31–34,36,40,47,49,51–54,66,67,69,70].
Function Enzyme Effect on neural development References
HAT CBP Required for neuronal development Tanaka, 2000; Lee,
2009; Wang, 2010
P300 Required for astrocyte development,
promotes axonal regeneration
Cheng, 2011;
Nakashima, 1999;
Gaub, 2011
GCN5 HAT activity needed for neural tube
closure
Bu, 2007
HDAC HDAC1 Blocks premature differentiation of
NSCs, required for oligodendrocyte
differentiation
Ye, 2009; Jacob, 2011;
Chen, 2011; Akhtar,
2009
HDAC2 Blocks premature differentiation of
NSC, required for oligodendrocyte
differentiation
Ye, 2009; Jacob, 2011;
Chen, 2011; Akhtar,
2009
HDAC1-
3
VPA stimulates neurogenesis,
inhibits oligodendrocyte
differentiation
Hsieh, 2004; Laeng
2004
HDAC5 Promotes neural stem cell
proliferation
Sun, 2007
HDAC9 Regulates dendritic growth Sugo, 2010
Sirt1 Inﬂuences neuronal differentiation Zhang, 2011;
Prozorovski, 2008;
Wallenborg, 2009
DNMT DNMT1 Required for neural cell viability Fan, 2001
DNMT3a Required for neuromuscular junction Nguyen, 2007
HMT Mll1 Controls neurogenesis Lim, 2009
G9a Prevents misexpression of neural
genes, required for neurogenesis
Roopra, 2004
Ezh2 Controls neural stem cell state,
prevents premature differentiation
Rai, 2010
Pereira, 2010
HDM LSD1 Controls neural stem cell
proliferation
Sun, 2010
Jarid2a Control repression of pluripotency
genes during neural differentiation
Schmitz, 2011
JMJD3 Promotes neuronal differentiation Jepsen, 2007
KDM7 Required for neural development Tsukada, 2010
Jarid1c/
SMCX
Required for neuronal survival and
dendrite development
Iwase, 2007
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substances, such as valproic acid, neurodevelopmental disorders includ-
ing mental retardation, pediatric tumors of the nervous system, and
predisposition for developing disease in adulthood.
2. Histone acetyl transferases (HATs)
Histones H3 and H4 can be acetylated on several lysines on their
N-terminal tails and the acetylation level of histones in a promoter is
positively correlated to an active transcription, but the enzymes that
acetylate the histones in vivo are not well studied in a developmental
context, not even in cellular systems. The fact that the substrate
speciﬁcity of the HATs is fairly low when studied in vitro makes it
difﬁcult to couple speciﬁc acetylated residues to any single enzyme.
Many of the HATs also acetylate non-histone proteins, which also
complicate the interpretation of the phenotypes observed in acetyl
transferase (AT) knock-out mice [5]. CBP and p300 are large, similar
proteins that interact with many different transcription factors and
are shown to have both AT activity as well as non-enzymatic func-
tions where they act as scaffolds bringing the general transcriptional
machinery and the DNA binding transcription factors together [6].
Mutations in either factor cause Rubinstein–Taybi syndrome, a disease
in part characterized by mental retardation. One example of a non-
enzymatic function of CBP is the ﬁnding that ES cells from CBP AT
activity deﬁcient mice surprisingly respond to bone morphogenetic
protein 2 (BMP2) signaling by upregulating BMP-inducible genes to a
similar if not higher level than wild type ES cells [5]. However, the AT
activity of the enzymes is essential to mouse development since
deﬁciency in AT activity is embryonic lethal [5]. Nevertheless, there are
several studies linking HATs to neural development (Table 1, Fig. 1)
even though knockouts of the whole protein do not differentiate
between CBP/P300 activities on histone acetylation and other functions
of the proteins. Mice mutant for CBP die around embryonic day (E) 12
with malformations of the central nervous system as a result of failure
to close the dorsal tube cranially [7], which implicates CBP function
during early neural development. Similar observationsweremade early
in the p300 mutant mice [8]. In addition, neural lineage decision has
been linked to functional CBP activity [9] and development of motor
neurons in the spinal cord has been shown to be dependent on CBP
through a synergistic interaction with retinoic acid receptor (RAR) and
Neurogenin2 [10]. CBP and p300 can bemodiﬁed post-translationally at
several positions, and phosphorylation of CBP by atypical protein kinase
Cζ controls the AT activity. This phosphorylation has been shown to be
necessary for histone acetylation of neural promoters and neuronal
differentiation [11]. Regeneration in response to injury is also related
to development and nerve injury models have been used to study the
formation of nerves. Thus, in an ocular nerve model of nerve damage,
p300 overexpression was observed to promote axonal regeneration
[12].
Apart from neurogenesis, HATs have also been implicated in
astrocytic differentiation. Neural stem cell differentiation into astro-
cytes has been shown to be dependent on synergistic signaling between
leukemia inhibitory factor (LIF) and BMP2 [13]. These signals are
coordinated by p300 acting as a bridge between STAT3 and Smad1
representing the downstream signals in the LIF and BMP2 signaling
cascades [13]. CBP and p300 have also been implicated in astrocytic
differentiation in differentiating Ntera2 cells, where CBP and p300 are
recruited directly to the astrocytic marker glial ﬁbrillary acidic protein
(GFAP) promoter and facilitate transcription [14].
In several of these studies, CBP/p300 has been suggested to act as
signaling hubs that integrate the activity of several transcriptional
activators from different signaling pathways [10,13] and it is impor-
tant to note that this seems to be a general role for CBP and p300 in
neural development. In addition to the CBP and p300 studies the
Gcn5 HAT has also been implicated in neural development since mice
with a point mutation in the HAT domain of Gcn5 show neural tubeclosure effects [15]. More studies on other HATs than CBP and p300 in
neural stem cells and brain development will be of interest to
increase the understanding for speciﬁc roles of histone acetylation in
these events.
3. Histone deacetylases (HDACs)
HDACs are generally divided into four classes. Class I HDACs (HDAC1,
2, 3 and 8) are most closely related to the yeast transcriptional regulator
Rpd3 and are sensitive to the HDAC inhibitor Valproic acid (VPA) that is
clinically widely used to treat epilepsy and bipolar disorder [16]. Class II
HDACs (HDAC4, 5, 6, 7, 9 AND10) share domains that have similarities in
the yeast deacetylase HDA1. Common HDAC inhibitors, such as
Trichostatin A (TSA), block HAT activities from both class I and class II
HDACs. Class III HDACs are also called sirtuins after the foundingmember
Sir2 in yeast. These are NAD+ dependent enzymes and at least a subset
of these can be activated by the well-studied and discussed polyphenol
resveratrol. Class IV only contains one HDAC (HDAC 11) and has
characteristics of both class I and Class II HDACs. The expression of HDAC
11 is cytoplasmic which suggest a non-histone deacetylation function
(for extensive review on HDACs, please see [17]).
4. Effects of chemical inhibitors of HDACs
As HAT activity is affecting neural differentiation it is not surprising
that also HDAC activity, which counteracts histone acetylation, can
affect neural differentiation.Many studies have used chemical means of
inhibiting HDAC activity in different systems. In neuronal cells, the
histone deacetylase inhibitors TSA and sodium butyrate were observed
Fig. 1. Graphical summary of histone-modifying enzymes in neural development and differentiation. The classes of enzymes are color coded following the order of the abbreviations
in the square upper right. Abbreviations: HAT, histone acetyl transferase; HDAC, histone deacetylase; HMT, histone methyl transferase; HDM, histone demethylase: DNAmeth, DNA
methyl transferase; ES, embryonic stem cells; NSC, neural stem cell; NPC, neural precursor cell; Adult, adult neural stem cell.
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amide [18]. This apoptotic effect of TSA was seen when used at a
concentration of 1–3 μM. However, using a 15–30 fold lower TSA
concentration in another system where rat neonatal cortical pro-
genitors normally differentiate into oligodendrocytes in response to
mitogen withdrawal, TSA treatment inhibits the differentiation and the
progenitors remain in an undifferentiated state [19]. Similar to these
results is the ﬁnding that HDAC inhibition by TSA in oligodendrocyte
precursors can cause developmental plasticity whereby the cells can
develop into astrocytes and neurons [20].
Also the unrelated HDAC inhibitor VPA can affect neurogenesis by
stimulating neuronal development towards GABAergic neurons while
inhibiting astrocytic differentiation in rat and human fetal neural
stem cells [21]. In adult neural stem cells, VPA has been shown to
stimulate neurogenesis through an up-regulation of NeuroD, while
inhibiting glial fates [22].
It is important to note that histone deacetylase function and thus
histone acetylation has been implicated in many diseases, including
the neurodevelopmental disorder Rett syndrome, and it has therefore
been discussed whether HDAC inhibitors such as VPA can be used
therapeutically in treatment of some of these diseases [23]. Please
note therefore that many patients with such disease, including Rett
syndrome, due to epilepsy or other diagnoses, already are being
treated with VPA. Thus although HDAC inhibitor treatment may be
promising in many cases, a lot of caution should be taken when
speculating in the beneﬁciary effects of such drugs.
5. Class I HDACs
As chemical inhibitors against class I and class II HDACs thus have
profound effects on neural differentiation, it becomes interesting to
couple such effects to the speciﬁc HDAC enzymes (Table 1, Fig. 1).
Mice harboring gene deletions in the oligodendrocyte lineage for
HDAC1 or HDAC2 respectively have weak effects. However, in doubleknock-out mice where both HDAC1 and HDAC2 are eliminated, the
oligodendrocyte differentiation has been shown to be affected due to
effects on β-catenin signaling [24]. Also, conditional gene deletion of
HDAC1 and HDAC2 in peripheral Schwann cells leads to loss of cells
and absence of myelin [25]. HDAC2 was found to be required for
proper Sox10 expression and HDAC1 to regulate β-catenin activity. In
agreement with this, it was found that acetylation of the protein NFκB
is affected in HDAC1/2 double knock-out Schwann cells, which does
affect Sox10 expression as well as myelination of peripheral nerves
[26]. In hippocampal neurons, HDAC1 and HDAC2 were shown to
control synapse maturation and combined gene deletion of HDAC1
and HDAC2 resulted in premature synapse maturation [27]. Since
both VPA and TSA have been seen to have an inhibitory effect on
differentiation of glial fates this correlates well with the ﬁndings that
HDAC1 and 2 are used during glial differentiation in several systems.
HDAC3 is not as extensively studied during neural development but
in hippocampal pyramidal neurons it has been reported to inﬂuence the
acetylation levels of H4K8 and diminish long term memory formation
[28], and forced expression of HDAC3 results in increased cell death
of cortical neurons [29] indicating that it also contributes to the
neuronal function in adult. Interestingly, the toxicity of HDAC3 has been
suggested to be regulated by a balance in activity of the kinases Akt and
GSK3ß [29], similar to the associated corepressor NCoR1 [30].6. Class II HDACs
Class II HDACs are not as well studied as class I HDACs in relation
to neural development, and it has been shown that class I HDACs are
required for the activity of class II HDACs. Nevertheless, speciﬁc
functions of at least two class II HDACs have been reported. HDAC5 is
interacting with the orphan nuclear receptor Tlx (NR2E1) and repress
p21 expression thereby controlling neural stem cell proliferation [31].
In addition, dendritic growth is regulated by the translocation of
Table 2
Protein complexes containing histonemodifying enzymes implicated in neural development.
References for the table: [74–80].
Complex Proteins References:
CoREST CoREST Lakowski, 2006; Perissi, 2010
CtBP1
CtBP2
HDAC1
HDAC2
LSD1
Sin3
NCoR/SMRT NCoR/SMRT Li, 2000; Underhill, 2000
CORO2A
GPS2
HDAC3
KAP1
TAB2
TBL1
TBLR1
NURD CHD4 Denslow, 2007; Perissi, 2010
HDAC1
HDAC2
LSD1
MBD3
MTA1–MTA3
Sin3 SIN3 Silverstein, 2005
HDAC1
HDAC2
RBAP46
RBAP48
SAP18
SAP30
PRC1 RING1 Simon, 2009
PHC1
PHC2
CBX4
BMI1
PRC2 EZH2 Simon, 2009
SUZ12
EED
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neurons [32].
7. Class III HDACs (sirtuins)
Also the class III HDAC Sirt1 has been implicated in neuronal
differentiation albeit with conﬂicting activity since it has been
implicated in both promotion and inhibition of neuronal differenti-
ation. Inhibition of Sirt1 by nicotinamide improved motor neuron
differentiation from ESC [33]. Similarly, Sirt1 has been suggested to
act together with Hes1 and TLE1 to repress Mash1 expression and
neural differentiation in neural precursor cells [34] associated with an
effect on lysine 9 on histone H3 (H3K9). It should be noted that the
effects of Sirt1 onH3K9 acetylation is debated as it is primarily targeting
lysine 16 on histone H4 (H4K16; [35]). Also in rat cortical neural stem
cells, stimulation by resveratrol inhibited neuronal differentiation in a
Sirt1-dependent way [36].
On the other hand, overexpression of cytoplasmic Sirt1 stimulated
nerve growth factor dependent neurite outgrowth whereas a domi-
nant negative cytoplasmic Sirt1 suppressed it [37]. Sirt1 has also been
found to bind repressor complexes, and overexpression of Sirt1
promoted neuronal differentiation of neural precursor cells (NPCs)
while knockdown inhibited differentiation. This could supposedly be
an effect of Sirt1 in the nucleus as overexpression of cytoplasmic Sirt1
did not promote differentiation [38] indicating that the nuclear
function of Sirt1 is needed for this effect. It is rather likely that Sirt1 is
involved in many complex events in a cell, and the outcome of Sirt1
activity on neural development could be secondary to, e.g., the
metabolic context and global changes in gene expression due to the
regulation of H4K16 acetylation.
8. HDAC associated transcriptional regulatory complexes
The function of HDACs in various differentiation pathways
depends on which genes the HDAC is recruited to and where it is
located. In many cases the recruitment of HDACs occurs in the context
of transcriptional regulatory protein complexes (Table 2). The nuclear
receptor corepressor (NCoR) and the homologous protein NCoR2
(silencing mediator for retinoid or thyroid hormone receptor, SMRT)
are co-repressors that recruit HDAC3. HDAC3 has been suggested to
achieve a repressed state and a stable corepressor complex by
ordered deacetylation of H4 tail lysines [39]. A speciﬁcity with regard
to controlling lineage fate of the NCoR versus the NCoR2/SMRT
complexes have been observed in neural stem cells (NSCs) which
may be explained by recruitment target site or possibly by variable
protein complex components including HDACs. It has been demon-
strated that NCoR controls astrocyte differentiation at least in part by
directly repressing GFAP transcription [30] while NCoR2/SMRT specif-
ically controls neuronal differentiation by repressing retinoic acid
receptor target genes in the absence of retinoic acid [40]. HDAC1,
HDAC2 and HDAC3 can be recruited to chromatin through interactions
with Sin3 (HDAC1, HDAC2) or via complexes includingNCoR or NCoR2/
SMRT to which HDAC3 binds directly (Table 2), which bind chromatin
through interactions with deacetylated histone H3 in vitro [41]. In
Ntera2 cells, which share some features with adult neuronal precursor
cells Sin3a has been shown to be associated with the GFAP promoter
when the cells are kept undifferentiated,whereas during differentiation
Sin3a is downregulated [14]. This indicates that Sin3a repression and
associated HDAC activity are needed to prevent premature expression
of GFAP in differentiating Ntera2 cells.
In HeLa cells, repression by NCoR and NCoR2/SMRT complexes is
dependent not only on the receptor that recruits the complex but also
on interactions with deacetylated histones mediated by the associat-
ed HDAC activity [42]. Any possible substrate speciﬁcity for HDAC-
associated complexes in neural development remains however to be
elucidated.Repressor element 1 silencing transcription factor (REST) is func-
tioning together with a complex of several other proteins (Table 2)
with several enzymatic activities such as HDAC1/2, the histone
methyl transferase G9a and the histone demethylase LSD1, and is
further reviewed in [43]. The REST complex inhibits neural speciﬁc
genes through interactions with Sin3a and HDAC2 [44] and is needed
for maintenance of pluripotency of embryonic stem cells as well as for
neural induction. When REST is ablated in radial glia like neural stem
cells, the generated astrocytes and oligodendrocytes do not stop ex-
pressing neuronal genes [45]. The REST cofactor CoREST has functions
independent from REST in NSC and is associated with pluripotency
genes. Differentiation of NSC fromCoREST deﬁcient cells leads to a bigger
fraction of neuronswhile the number of astrocytes and oligodendrocytes
are diminished [46]. Taken together this indicates an involvement
of REST and CoREST complexes in controlling the timing of neural
differentiation.
9. Histone methyl transferases (HMT)
Themethylation of histones especially of histone 3 at residues H3K4,
H3K9 and H3K27 is emerging as some of the key epigenetic marks that
control transcription in stem cells and progenitors. Methylation of
H3K4, especially trimethylation, has been tightly linked to active
transcription whereas methylation of H3K9 and H3K27 are bona ﬁde
marks of repressive chromatin. H3K9me is bound by HP1 and regulates
heterochromatin formation and H3K27me recruits the well-studied
PRC1 polycomb complex.
Mll1 is a histone methyl transferase methylating H3K4 and has
been associated with the trithorax group of transcription factors. In
mice where Mll1 is knocked out in neural stem cells, postnatal
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promoter and in knock out NSC Dlx2 expression is diminished.
Surprisingly, the loss of Mll1 did not affect the methylation of H3K4
on the Dlx2 promoter but H3K27me3 is increased, indicating that
Mll1 is recruiting a H3K27 demethylase [47]. Ezh2, the histone
methyl transferase of the PRC2, is needed for correct gene repression
in the developing cortex since genetic deletion leads to a premature
differentiation and loss of H3K27me3 in the mid-gestation cortex
thereby indirectly promoting astrocytic differentiation [48,49]. The
demand for modulation of H3K27me during neural development has
also been seen genome wide during differentiation of ES cells to
neural progenitors and further to terminal pyramidal neurons [50].
During this process H3K27me is highly variable on many promoters
highlighting the need for enzymes that add and remove H3K27me.
The methyl transferase G9a interacts with REST and methylates
H3K9 on REST target genes, and expression of a dominant negative
G9a lead to dysfunctional regulation of neuronal genes (Table 1;
[51]). In zebraﬁsh, the histone methyl transferase G9a is also needed
for neurogenesis through repression of Lef1. In this setting G9a
cooperated with the DNA methyl transferase DNMT3 which also
represses Lef1 expression [52] illustrating the cooperativity between
DNA methylation and H3K9 methylation in repression (Fig. 1). The
DNA methyl transferase DNMT1 is needed to maintain DNA methyl-
ation in dividing cells after replication when the newly synthesized
DNA strand needs to be methylated similarly to the older strand to
maintain methylation levels. DNMT1 knockout mice die at gastrula-
tion, which makes it impossible to study requirements of DNMT1
during later development. Whereas the effects of deleting DNMT1 are
detrimental [53] the effects of knocking out the de novo methylase
DNMT3a in the nervous system are less severe but lead to neuromus-
cular defects and a shortened lifespan [54]. Conditional micemodels for
DNAmethyl transferases have been generated, but also in thesemodels,
the cellular effects are severe and speciﬁc roles for the enzymes in
neural stem cells and development have been difﬁcult to elucidate.
Postnatally, it has been demonstrated that a double knockout of DNMT1
and DNMT3a in forebrain excitatory neurons as targeted by CaMKII
expression has effects on long-term plasticity in the hippocampal CA1
region as well as learning and memory deﬁcits [55]. It will be helpful in
future studies to use inducible or a wider range of transgenic mice
expressing Cre recombinase regulated by various promoters expressed
in different classes of neural progenitors during embryonic development.10. Histone demethylases (HDMs)
For a long time it was unclear whether histone methylation was
regulated by enzymes with opposing effects, in a similar way as other
histone modiﬁcations. Before demethylating enzymes were identi-
ﬁed, the general idea was that histone or histone-tail replacement
was required in order to remove amethyl-mark. However, identiﬁcation
of the arginine deiminase PADI4/PAD4 in 2004 suggested a dynamic
regulation of themodiﬁcation even though it was not a demethylase per
se [56,57]. Shortly after this ﬁnding, the ﬁrst evidence of an enzymewith
a histone demethylase activity was presented as LSD1/KDM1 and was
shown to demethylate H3K4 mono and dimethylation [58].
Enzymes belonging to the JmjC-domain containing protein family
that targets trimethylation marks were identiﬁed a couple of years later
(JHDM1 [59], GASC1 [60], Jmjd2b [61], JHDM3A [62], JMJD2 [63]). Since
then, several classes of demethylases have been reported, reviewed in
[64,65]. Histone demethylases are today recognized as crucially involved
in regulating cell function including differentiation. Speciﬁcally enzymes
regulating H3K4, H3K9 and H3K27 methylation have a key role in dif-
ferentiation since these modiﬁcations are potent effectors of chromatin
environment. A limited but nonetheless crucially important list of
demethylases has so far been shown to regulate neural development
(Table 1, Fig. 1).The consequence of genetic deletion of NCoR2/SMRT was a
derepression of genes that promote neuronal differentiation both in
isolated cortical progenitor cells as well as in vivo [40]. One of those
derepressed genes were found to be JMJD3/KDM6B (Table 1), a gene
belonging to the JmjC-domain protein family, and it was shown to be
actively involved in promoting speciﬁc pathways in the neurogenic
program by demethylation of H3K27me3.
KDM7, another JmjC-domain containing gene has been reported to
catalyze the demethylation of mono- or di-methylated H3K9 and H3K27
[66]. These histone marks have been associated with transcriptional
silencing and KDM7-dependent removal of the speciﬁc residue methyl-
ation load was found to affect the tectum size due to loss of neurons in
this area and thereby affecting brain development in zebraﬁsh. In
addition, KDM7 dependent demethylation directly regulates the Follis-
tatin gene in mouse Neuro2A cells implicating this enzyme to be
involved in neural development also in mammals.
LSD1, the ﬁrst demethylase from 2004, has been shown to serve as
a key regulator of neural stem cell proliferation (Table 1; [67]). This
effect was mediated through Tlx‐dependent recruitment to known
cell proliferation genes like p21 and Pten. Using LSD1 inhibitors or
siRNA against LSD1 the mono- and-dimethyl levels on H3K4 at p21
and Pten promoters speciﬁcally increased. This epigenetic change
induced the expression of the p21 and Pten genes and inhibited cell
proliferation. In a different study, LSD1 was recently found to be
crucially involved speciﬁcally in embryonic stem cell differentiation but
however dispensable for maintaining ES cell state including prolifera-
tion (self-renewal) [68].
An essential role for the H3K4 di- and tri-demethylase Jarid1b
controlling ES cell differentiation along the neural lineage was recently
reported. Removal of the enzyme with shRNA in cultivated ES cells did
not affect self-renewal but did affect a proper repression of pluripotency
genes during differentiation [69].
Jarid1c/SMCX is another JmjC-domain protein speciﬁcally demethy-
lating H3K4me3 to a mono- or di‐methylated product [70]. Iwase et al.
showed that SMCX plays a role in neuronal survival and dendrite
development both in zebraﬁsh and importantly also in primarymamma-
lian neurons. As the authors point out, the clinical syndrome X-linked
mental retardation has interestingly been associated with several point
mutations in the SMCX gene [71–73]. Importantly, these mutations are
linked to a dysfunctional H3K4me3 demethylase activity providing a
molecular mechanism involving a histone-modifying enzyme directly
underlying an intellectual disability condition.
Overall, although histone demethylases have only been recognized
for a few years, the implications of these enzymes in stem cell regulation,
including neural stem cells, and development are profound. It will be of
great interest in the near future to study the dynamic regulation of
histonemethylation in neural stem cell lineage decision aswell as during
neuronal and glial differentiation and nervous system development in
health and disease.
11. Conclusion
Taken together, enzymes controlling histone acetylation and meth-
ylation seem to be involved in thewhole process of neural development,
from controlling proliferation and undifferentiated but “poised” state of
stem cells to promoting and inhibiting neurogenic and gliogenic
pathways and neuronal survival as well as neurite outgrowth (Table 1,
Fig. 1). Aberrations in the enzymatic activity of histone acetyl trans-
ferases, deacetylases, and demethylases have already been chemically
(VPA) and genetically (Rubinstein–Taybi Syndrome, X-linked mental
retardation) linked to neural developmental disorders, and aberrancies
in the activities of histone deacetylation and demethylases have been
associated with pediatric tumors in the nervous system. Future studies
need to link the genetic and developmental studies to more in-depth
biochemical characterization to provide a clearer picture of how to
improve the diagnosis, prognosis, and treatment of such disorders.
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